new glp-1 drug retatrutide Promises Big Weight Loss, but Safety Remains a Question Understanding the Next-Gen Weight Loss
Description
& Jones, B
Recent economic analyses have made this clearer
Nature (2017) 546:24853
Regular follow-up appointments are essential during GLP-1 therapy, typically aligning with the medication's titration schedule (often every 4 weeks initially) and as clinically indicated
Athauda D, Maclagan K, Skene SS, et al
